Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-015423
Filing Date
2022-03-28
Accepted
2022-03-28 13:31:44
Documents
101
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_ayalapharma.htm   iXBRL 10-K 1625760
2 DESCRIPTION OF SECURITIES f10k2021ex4-3_ayalapharma.htm EX-4.3 29988
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2021ex23-1_ayalapharma.htm EX-23.1 2809
4 CERTIFICATION f10k2021ex31-1_ayalapharma.htm EX-31.1 9999
5 CERTIFICATION f10k2021ex31-2_ayalapharma.htm EX-31.2 9875
6 CERTIFICATION f10k2021ex32-1_ayalapharma.htm EX-32.1 4335
7 CERTIFICATION f10k2021ex32-2_ayalapharma.htm EX-32.2 4434
8 RESOLUTIONS ADOPTED BY THE BOARD OF DIRECTORS OF THE REGISTRANT SETTING FORTH TH f10k2021ex99-1_ayalapharma.htm EX-99.1 18224
9 GRAPHIC image_001.jpg GRAPHIC 108965
10 GRAPHIC image_002.jpg GRAPHIC 85188
11 GRAPHIC image_003.jpg GRAPHIC 28383
12 GRAPHIC image_004.jpg GRAPHIC 44323
13 GRAPHIC image_005.jpg GRAPHIC 41003
14 GRAPHIC image_006.jpg GRAPHIC 94726
15 GRAPHIC image_007.jpg GRAPHIC 25594
16 GRAPHIC image_008.jpg GRAPHIC 36043
17 GRAPHIC image_009.jpg GRAPHIC 31817
18 GRAPHIC image_010.jpg GRAPHIC 31724
19 GRAPHIC image_011.jpg GRAPHIC 33172
20 GRAPHIC image_012.jpg GRAPHIC 47249
21 GRAPHIC image_013.jpg GRAPHIC 74692
22 GRAPHIC image_014.jpg GRAPHIC 36442
23 GRAPHIC image_015.jpg GRAPHIC 32870
24 GRAPHIC image_016.jpg GRAPHIC 37864
25 GRAPHIC image_017.jpg GRAPHIC 40481
26 GRAPHIC image_018.jpg GRAPHIC 89567
27 GRAPHIC image_019.jpg GRAPHIC 65535
28 GRAPHIC image_020.jpg GRAPHIC 97430
29 GRAPHIC image_021.jpg GRAPHIC 152787
30 GRAPHIC image_022.jpg GRAPHIC 68251
31 GRAPHIC image_023.jpg GRAPHIC 79359
32 GRAPHIC image_026.jpg GRAPHIC 42577
33 GRAPHIC image_027.jpg GRAPHIC 45371
34 GRAPHIC image_028.jpg GRAPHIC 51733
35 GRAPHIC image_029.jpg GRAPHIC 20301
36 GRAPHIC image_030.jpg GRAPHIC 33146
37 GRAPHIC image_031.jpg GRAPHIC 4319
  Complete submission text file 0001213900-22-015423.txt   9920917

Data Files

Seq Description Document Type Size
38 XBRL SCHEMA FILE ayla-20211231.xsd EX-101.SCH 58230
39 XBRL CALCULATION FILE ayla-20211231_cal.xml EX-101.CAL 21273
40 XBRL DEFINITION FILE ayla-20211231_def.xml EX-101.DEF 241029
41 XBRL LABEL FILE ayla-20211231_lab.xml EX-101.LAB 494680
42 XBRL PRESENTATION FILE ayla-20211231_pre.xml EX-101.PRE 253478
95 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_ayalapharma_htm.xml XML 528677
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

EIN.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39279 | Film No.: 22774579
SIC: 2836 Biological Products, (No Diagnostic Substances)